AMGAnna Maria GerettiMD, PhD, FRCPathVideoViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025HBV Reactivation Risk with Antiretroviral Regimens Omitting TDF/TAF - Anna Maria GerettiView Video
VideoViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025Abstract #21 Viral Strain Networks Tracing Human or Environment-Linked Hepatitis E Virus Dispersion in Europe: HEV Molecular Signatures - Evelyne SchvoererView Video
SlidesetViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025Abstract #21 Viral Strain Networks Tracing Human or Environment-Linked Hepatitis E Virus Dispersion in Europe: HEV Molecular Signatures - Evelyne SchvoererView Slideset
FGFederico GarcíaPharmD, PhDVideoViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025Abstract #20 Boosting HDV Testing in Spain through the Delta Double Reflex Strategy - Federico GarcíaView Video
FGFederico GarcíaPharmD, PhDSlidesetViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025Abstract #20 Boosting HDV Testing in Spain through the Delta Double Reflex Strategy - Federico GarcíaView Slideset
VideoViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025Abstract #19 Despite a Substantial Burden of HDV Infection, Gaps in HDV Screening Still Persists Across Europe: An Urgent Need to Strengthen Diagnostic Strategies at a Pan-European Level - Ilaria GrossiView Video
SlidesetViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025Abstract #19 Despite a Substantial Burden of HDV Infection, Gaps in HDV Screening Still Persists Across Europe: An Urgent Need to Strengthen Diagnostic Strategies at a Pan-European Level - Ilaria GrossiView Slideset
SlidesetViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025HCV Micro-Elimination Approaches: IV Drug Users – Spilios ManolakopoulosView Slideset
PKPavel KhaykinMDVideoViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025HCV Elimination: Why Do We Still Have Gaps and How Do We Close These Gaps? - Pavel KhaykinView Video
PKPavel KhaykinMDSlidesetViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025HCV Elimination: Why Do We Still Have Gaps and How Do We Close These Gaps? - Pavel KhaykinView Slideset
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #17 Clonal Analysis of Near Full-Length Proviral HIV-1 Genome Enables Differentiation of APOBEC- and Drug-Resistant Populations in Highly Treatment Experienced People Living with HIV - Martin DäumerView Video
SlidesetHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #17 Clonal Analysis of Near Full-Length Proviral HIV-1 Genome Enables Differentiation of APOBEC- and Drug-Resistant Populations in Highly Treatment Experienced People Living with HIV - Martin DäumerView Slideset
